Search Results for "aliskiren"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for aliskiren. Results 11 to 13 of 13 total matches.

Once-Daily Mesalamine (Lialda) for Ulcerative Colitis

   
The Medical Letter on Drugs and Therapeutics • Mar 26, 2007  (Issue 1257)
: Aliskiren (Tekturna) for Hypertension Female Sexual Dysfunction Dermal Fillers Coming Soon in Treatment ...
A once-daily oral formulation of mesalamine (Lialda - Shire) was recently approved by the FDA for induction of remission in patients with mild to moderate ulcerative colitis.
Med Lett Drugs Ther. 2007 Mar 26;49(1257):25-6 |  Show IntroductionHide Introduction

Pramipexole (Mirapex) for Restless Leg Syndrome

   
The Medical Letter on Drugs and Therapeutics • Mar 26, 2007  (Issue 1257)
Letter: Aliskiren (Tekturna) for Hypertension Female Sexual Dysfunction Dermal Fillers Coming Soon ...
The dopamine agonist pramipexole (Mirapex - Boehringer Ingelheim) is the second drug approved by the FDA for treatment of moderate to severe restless legs syndrome (RLS). Ropinirole (Requip), another dopamine agonist, was approved for RLS in 2005. Both of these drugs were first approved for treatment of Parkinson's disease.
Med Lett Drugs Ther. 2007 Mar 26;49(1257):26-8 |  Show IntroductionHide Introduction

Drugs for Treatment and Prevention of Venous Thromboembolism

   
The Medical Letter on Drugs and Therapeutics • Jul 25, 2022  (Issue 1655)
the hyperkalemic effects of ARBs, ACE inhibitors, potassium-sparing diuretics, aliskiren, and canagliflozin ...
Anticoagulants are the drugs of choice for treatment and prevention of deep venous thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboembolism (VTE). US guidelines for treatment of VTE were updated in 2020 and 2021.
Med Lett Drugs Ther. 2022 Jul 25;64(1655):113-20 |  Show IntroductionHide Introduction